Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-09 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -6.060 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
COGT | Cogent Biosciences | 8.71 | 0.03 | 0.35% | 324M |
You can purchase shares of Cogent Biosciences (NASDAQ: COGT) through any online brokerage.
Other companies in Cogent Biosciences’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Centogene (NASDAQ:CNTG) and Kezar Life Sciences (NASDAQ:KZR).
The latest price target for Cogent Biosciences (NASDAQ: COGT) was reported by Piper Sandler on 2020-12-23. The analyst firm set a price target for 22.00 expecting COGT to rise to within 12 months (a possible 152.58% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Cogent Biosciences (NASDAQ: COGT) is $8.71 last updated Thu Apr 22 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Cogent Biosciences.
There is no upcoming split for Cogent Biosciences.